Company Filing History:
3 out of 2,483 
3 out of 1,152 
2 out of 151 
Years Active: 2014-2021
Title: Thomas Gundinger: Innovator in Immunoglobulin Preparation
Introduction
Thomas Gundinger is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of immunology, particularly in the production of immunoglobulin preparations. With a total of five patents to his name, Gundinger's work has advanced the methods used in the manufacturing of intravenous immunoglobulin (IVIG) products.
Latest Patents
Gundinger's latest patents include a method to produce an immunoglobulin preparation with improved yield. This invention provides enhanced methods for manufacturing IVIG products, offering advantages such as reduced loss of IgG during purification and improved quality of final products. Additionally, it presents aqueous and pharmaceutical compositions suitable for various forms of administration, including intravenous, subcutaneous, and intramuscular routes. Another significant patent involves the fraction I-IV-1 precipitation of immunoglobins from plasma. This invention outlines methods for manufacturing blood protein compositions from pooled plasma, utilizing an alcohol fractionation scheme that significantly increases the yield of blood proteins purified from the starting plasma sample.
Career Highlights
Throughout his career, Gundinger has worked with prominent companies in the healthcare sector, including Baxter International Inc. and Baxter Healthcare. His experience in these organizations has contributed to his expertise in the field of immunoglobulin production and blood protein purification.
Collaborations
Gundinger has collaborated with notable professionals in his field, including Leopold Bruckschwaiger and Wolfgang Teschner. These collaborations have likely enriched his research and development efforts, leading to innovative solutions in immunology.
Conclusion
Thomas Gundinger's contributions to the field of immunology through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the manufacturing processes of immunoglobulin preparations, improving the quality and efficacy of therapeutic products.